Benzinga's Top Initiations

Analysts at Roth Capital initiated coverage on Spark Therapeutics, Inc. ONCE with a Buy rating. The target price for Spark Therapeutics is set to $71. Spark Therapeutics' shares closed at $46.00 yesterday. Analysts at Pacific Crest initiated coverage on Proto Labs, Inc. PRLB with a Sector Perform rating. Proto Labs' shares closed at $71.07 yesterday. Barrington Research initiated coverage on HealthEquity, Inc. HQY with a Outperform rating. The target price for HealthEquity is set to $25. HealthEquity shares closed at $20.13 yesterday. Analysts at Chardan Capital initiated coverage on Avalanche Biotechnologies, Inc. AAVL with a Neutral rating. The target price for Avalanche Biotechnologies is set to $40. Avalanche Biotechnologies' shares closed at $39.74 yesterday.